← All trials
NCT05124314
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 27, 2021
- Primary completion
- Oct 31, 2023
- Completion date
- Oct 31, 2023
- First posted
- Nov 17, 2021
- Last posted
- Nov 17, 2021
- Enrollment
- 220
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Clinical Hospital MerkurLead sponsor
- University of ZagrebCollaborator
- Clinical Hospital MerkurReponsible party - principal investigator
- Clinical Hospital MerkurOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.